Although CD138 is well recognized to be expressed on MM cells (49), it has been recently reported that few MM clones lacks the expression of CD138 and these CD138-negative cells may represent a group of cancer stem cells with a higher migration capacity (50, 51). This evidence concerns the gene SDC1 and Miyoshi myopathy.